Programme launched to support lung disease treatment
As many as 150 outpatient centres treating chronic asthma and chronic obstructive pulmonary disease (COPD) will be built at total investment of 1 million USD by AstraZeneca multinational pharmaceutical and biopharmaceutical company under the “Health lung” programme.
150 outpatient centres treating chronic asthma and chronic obstructive pulmonary disease (COPD) will be built by AstraZeneca under the “Health lung” programme. (Photo: sggp.org.vn)
Da Nang (VNA) – As many as 150 outpatient centres treatingchronic asthma and chronic obstructive pulmonary disease (COPD) will be builtat total investment of 1 million USD by AstraZeneca multinationalpharmaceutical and biopharmaceutical company under the “Health lung” programme.
The programme was launched by the Vietnam Medical Association, the VietnamRespiratory Society, the Vietnam Association against Tuberculosis and LungDiseases and AstraZeneca company in the central city of Da Nang on September21.
It aims to enhance management of asthma and COPD, contributing to reducing casesand deaths.
According to President of the Vietnam Respiratory Society Ngo Quy Chau, peoplediagnosed with COPD accounts for 4.2 percent of total population and most ofthem are at the age of 40. However, only 29.1 percent of the asthma patients,who make up 4.1 percent of total population, are taking medication while 39.7percent have good control of the disease.
Along with cigarettes and environmental pollution, pulmonary tuberculosis hasincreased risk of COPD, which puts a burden on society, Chau underlined.
Meanwhile, Le Thi Tuyet Lan, President of the Society of Asthma & Allergy& Clinical Immunology and Vice President of the Vietnam RespiratorySociety, said that the outpatient treatment network will help reduce economic andhealth care burdens for Vietnam.-VNA
The Military Medical Academy announced on February 22 that the first lung transplant with the lung donated by alive persons has been conducted successfully in Vietnam.
The Da Nang’s Oncology Hospital, in cooperation with the biopharmaceutical firm AstraZeneca, has launched its first-ever Epidermal growth factor receptor (EGFR) mutation testing programme.
Doctors at HCM City’s Binh Dan Hospital have used a robot for the first time in the country for lung cancer surgery, removing suspicious nodules through a small incision instead of a large one and without using mechanical rib spreaders, unlike in the past.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
150 outpatient centres treating chronic asthma and chronic obstructive pulmonary disease (COPD) will be built by AstraZeneca under the “Health lung” programme. (Photo: sggp.org.vn) 
